EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), a biotechnology company focused on the development of autologous (personalized) cell therapies for aesthetic, medical and scientific applications, announced today that David Pernock, the Company’s Chairman and CEO, will be presenting at the ROTH 23rd Annual OC Growth Stock Conference to be held on March 13-16 at the Ritz-Carlton in Laguna Niguel, California.
